Increased immunoreactivity to SLIT/ROBO1 and its correlation with severity of dysmenorrhea in adenomyosis

Fertility and Sterility

Volumn 95, Issue 3, 2011, Pages 1164-1167

  Nie, Jichan ^a   Liu, Xishi ^a   Zheng, Yu ^a   Geng, Jian Guo ^b   Guo, Sun Wei ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adenomyosis; dysmenorrhea; immunohistochemistry; MVD; ROBO1; severity; SLIT

Indexed keywords

CD34 ANTIGEN; GLYCOPROTEIN; ROUNDABOUT 1 PROTEIN; SLIT PROTEIN; UNCLASSIFIED DRUG;

ADENOMYOSIS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSMENORRHEA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOLOGICAL MARKERS; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE TISSUE PROTEINS; PREDICTIVE VALUE OF TESTS; RECEPTORS, IMMUNOLOGIC; SEVERITY OF ILLNESS INDEX;

EID: 79951947267     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.09.027     Document Type: Article

References (27)

1. Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006;20:511-21. (Pubitemid 44688626)
2. Peric H, Fraser IS. The symptomatology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006;20:547-55. (Pubitemid 44688621)
3. Nie J, Lu Y, Liu X, Guo SW. Immunoreactivity of progesterone receptor isoform B, nuclear factor kB, and IkBα in adenomyosis. Fertil Steril 2009;92:886-9.
4. Nie J, Liu X, Guo SW. Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis. Am J Obstet Gynecol 2010;202: 346.e1-8.
5. Cirpan T, Yeniel O, Ulukus M, Ozbal A, Gundem G, Ozsener S, et al. Clinical symptoms and histopathological findings in subjects with adenomyosis uteri. Clin Exp Obstet Gynecol 2008;35:48-53. (Pubitemid 351345817)
6. Groothuis PG, Nap AW, Winterhager E, Grummer R. Vascular development in endometriosis. Angiogenesis 2005;8:147-56. (Pubitemid 41712844)
7. Ota H, Igarashi S, Tanaka T. Morphometric evaluation of stromal vascularization in the endometrium in adenomyosis. Hum Reprod 1998;13:715-9. (Pubitemid 28171975)
8. Schindl M, Birner P, Obermair A, Kiesel L, Wenzl R. Increased microvessel density in adenomyosis uteri. Fertil Steril 2001;75: 131-5. (Pubitemid 32041234)
9. McLaren J, Prentice A, Charnock-Jones DS, Smith SK. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996;11:220-3. (Pubitemid 26047702)
10. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998;13:1686-90. (Pubitemid 28310515)
11. Deguchi M, Ishiko O, Sumi T, Yoshida H, Yamamoto K, Ogita S. Expression of angiogenic factors in extrapelvic endometriosis. Oncol Rep 2001;8:1317-9. (Pubitemid 33758738)
12. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann NY Acad Sci 2002;955:89-100, 118, 396-406.
13. Shen F, Liu X, Geng JG, Guo SW. Increased immunoreactivity to SLIT/ROBO1 in ovarian endometriomas: a likely constituent biomarker for recurrence. Am J Pathol 2009;175:479-88.
14. Wu JY, Feng L, Park HT, Havlioglu N, Wen L, Tang H, et al. The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2001;410:948-52. (Pubitemid 32335842)
15. Huminiecki L, Gorn M, Suchting S, Poulsom R, Bicknell R. Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. Genomics 2002;79:547-52. (Pubitemid 34274296)
16. Wang B, Xiao Y, Ding BB, Zhang N, Yuan X, Gui L, et al. Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 2003;4:19-29. (Pubitemid 36904158)
17. Bedell VM, Yeo SY, Park KW, Chung J, Seth P, Shivalingappa V, et al. Roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci USA 2005;102:6373-8. (Pubitemid 40617450)
18. Gronroos M, Salmi TA, Vuento MH, Jalava EA, Tyrkko JE, Maatela JI, et al. Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension. Cancer 1993;71:1279-82. (Pubitemid 23054919)
19. Wang LJ, Zhao Y, Han B, Ma YG, Zhang J, Yang DM, et al. Targeting Slit-roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis. Cancer Sci 2008;99:510-7. (Pubitemid 351228567)
20. Mai KT, Teo I, Al Moghrabi H, Marginean EC, Veinot JP. Calretinin and CD34 immunoreactivity of the endometrial stroma in normal endometrium and change of the immunoreactivity in dysfunctional uterine bleeding with evidence of 'disordered endometrial stroma'. Pathology 2008;40:493-9.
21. Wang-Tilz Y, Tilz C, Wang B, Tilz GP, Stefan H. Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy. Epilepsia 2006;47:233-9.
22. Liu X, Guo SW. Dysmenorrhea: risk factors in women with endometriosis. Womens Health (Lond Engl) 2008;4:399-411.
23. R Foundation for Statistical Computing. R: A language and environment for statistical computing. Available at: http://www.r-project.org. Accessed September 20, 2010.
24. Zhou YF, Mori T, Kudo H, Asakai R, Sassa S, Sakamoto S. Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice. Fertil Steril 2003;80(Suppl 2):788-94. (Pubitemid 37152395)
25. Casanovas O, Hicklin DJ, Bergers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 2005;8:299-309. (Pubitemid 41443415)
26. Carmeliet P. Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet 2003;4:710-20. (Pubitemid 37046138)
27. Morlot C, Thielens NM, Ravelli RB, Hemrika W, Romijn RA, Gros P, et al. Structural insights into the Slit-Robo complex. Proc Natl Acad Sci USA 2007;104:14923-8. (Pubitemid 47619569)